These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10878727)

  • 1. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations.
    Lai NS; Lan JL
    Lupus; 2000; 9(5):353-7. PubMed ID: 10878727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
    Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cerebrospinal fluid for the presense of anticardiolipin antibodies (aCL) in NP-SLE patients.
    Jedryka-Góral A; Zabek J; Wojciechowski B; Zaborski J; Chwalińska-Sadowska H; Członkowska A
    Clin Rheumatol; 2000; 19(4):306-10. PubMed ID: 10941814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.
    Martínez-Cordero E; Rivera García BE; Aguilar León DE
    J Investig Allergol Clin Immunol; 1997; 7(6):596-601. PubMed ID: 9491201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.
    Tan Z; Zhou Y; Li X; Wang G; Tao J; Wang L; Ma Y; Li X
    Clin Rheumatol; 2018 Jan; 37(1):227-233. PubMed ID: 29103181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement.
    Yeh TS; Wang CR; Jeng GW; Lee GL; Chen MY; Wang GR; Lin KT; Chuang CY; Chen CY
    Autoimmunity; 1994; 18(3):169-75. PubMed ID: 7858102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
    J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y; Yanagida T; Hirohata S
    Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
    Lu XY; Zhu CQ; Qian J; Chen XX; Ye S; Gu YY
    Lupus; 2010 May; 19(6):689-95. PubMed ID: 20179168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus.
    Yokoyama T; Fujii T; Kondo-Ishikawa S; Yamakawa N; Nakano M; Yukawa N; Yoshifuji H; Ohmura K; Mimori T
    Lupus; 2014 Jun; 23(7):635-42. PubMed ID: 24493282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus.
    Sasajima T; Watanabe H; Sato S; Sato Y; Ohira H
    J Neuroimmunol; 2006 Dec; 181(1-2):150-6. PubMed ID: 17064784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.
    Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA
    Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.